Peter J Mazzone
Overview
Explore the profile of Peter J Mazzone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
4075
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pennathur A, Lanuti M, Merritt R, Wolf A, Keshavarz H, Loo B, et al.
Semin Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39675493
The Clinical Practice Standards Committee of the American Association for Thoracic Surgery assembled an expert panel and conducted a systematic review of the literature detailing studies directly comparing treatment options...
2.
Wolf A, Loo B, Mak R, Liptay M, Pettiford B, Rocco G, et al.
Semin Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39674443
Stereotactic ablative radiotherapy (SABR) has emerged as an alternative, non-surgical treatment for high-risk patients with stage I non-small cell lung cancer (NSCLC) with increased use over time. The American Association...
3.
Merritt R, Brunelli A, Walsh G, Murthy S, Schuchert M, Varghese T, et al.
Semin Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39674442
Sublobar resection offers a parenchymal-sparing surgical alternative to lobectomy and includes wedge resection and segmentectomy. Sublobar resection has been historically utilized in high-risk patients with compromised lung function; however, the...
4.
Pennathur A, Lanuti M, Merritt R, Wolf A, Keshavarz H, Loo B, et al.
Semin Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39672521
Objectives: A significant proportion of patients with stage I non-small cell lung cancer (NSCLC) are considered at high risk for complications or mortality after lobectomy. The American Association for Thoracic...
5.
Pennathur A, Lanuti M, Merritt R, Wolf A, Keshavarz H, Loo B, et al.
Semin Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39662537
A significant proportion of patients with stage I non-small cell lung cancer (NSCLC) are considered at high risk for complications or mortality after lobectomy. The American Association for Thoracic Surgery...
6.
Lanuti M, Suh R, Criner G, Mazzone P, Marshall M, Tong B, et al.
Semin Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39662536
Image-guided thermal ablation (IGTA) applied to pulmonary pathology is an alternative to surgery in high-risk patients with stage I non-small cell lung cancer (NSCLC). Its application to lung neoplasm was...
7.
Pennathur A, Lanuti M, Merritt R, Wolf A, Keshavarz H, Loo B, et al.
Semin Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39662535
No abstract available.
8.
Kattih Z, Bade B, Hatabu H, Brown K, Parambil J, Hata A, et al.
Chest
. 2024 Oct;
167(3):781-799.
PMID: 39393485
Topic Importance: As interstitial lung abnormalities (ILAs) are increasingly recognized on imaging and in clinical practice, identification and appropriate management are critical. We propose an algorithmic approach to the identification...
9.
Fathi J, Barry A, Greenberg G, Henschke C, Kazerooni E, Kim J, et al.
Cancer
. 2024 Sep;
130(23):3961-3972.
PMID: 39302235
More than a decade has passed since researchers in the Early Lung Cancer Action Project and the National Lung Screening Trial demonstrated the ability to save lives of high-risk individuals...
10.
Volk R, Myers R, Arenberg D, Caverly T, Hoffman R, Katki H, et al.
Cancer
. 2024 Sep;
130(23):3996-4011.
PMID: 39302231
Shared decision making (SDM) between health care professionals and patients is essential to help patients make well informed choices about lung cancer screening (LCS). Patients who participate in SDM have...